Exelixis Inc. buy Wells Fargo & Company
Start price
30.10.24
/
50%
€29.87
Target price
30.10.25
€33.15
Performance (%)
10.91%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. The prediction had a final performance of 10.91%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 0.782% | 0.782% | 6.712% |
| iShares Core DAX® | -2.526% | -5.194% | 4.911% |
| iShares Nasdaq 100 | -0.032% | 1.561% | 21.789% |
| iShares Nikkei 225® | -4.202% | -7.550% | 31.128% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at Wells Fargo & Company from $32.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten